SCPH — SCPHARMACEUTICALS INC

Ownership history in ORBIMED ADVISORS LLC  ·  32 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.03% (2023 Q2)
Avg. % of fund
0.47%
First filed
2017 Q4
Last filed
2025 Q3
Quarters held
32
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 6,059,528 — 0% 0.81% $34.4M —
2025 Q2 UNCHANGED 6,059,528 — 0% 0.58% $23.1M —
2025 Q1 UNCHANGED 6,059,528 — 0% 0.38% $15.9M —
2024 Q4 UNCHANGED 6,059,528 — 0% 0.44% $21.5M —
28 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding SCPH

As of 2025 Q3 — sorted by position size

Yakira Capital Management, Inc. 3Y 7Y 0.87% Tejara Capital Ltd 3Y 0.73% Newtyn Management, LLC 3Y 7Y 0.65% APIS CAPITAL ADVISORS, LLC 3Y 7Y 0.55% Rangeley Capital, LLC 0.46% Balanced Rock Investment Advisors LLC 0.34% ALPINE ASSOCIATES MANAGEMENT INC. 3Y 7Y 0.33% Rubric Capital Management LP 3Y 7Y 0.33% GABELLI & Co INVESTMENT ADVISERS, INC. 3Y 7Y 0.28% GLAZER CAPITAL, LLC 3Y 7Y 0.26%
← Back to ORBIMED ADVISORS LLC Holdings